Peter Kolchinsky Is Betting Big On Achillion Pharmaceuticals, Inc. (ACHN), Wave Life Sciences (WVE) & More Heading Into 2016

Wave Life Sciences Ltd (NASDAQ:WVE) is the largest new position initiated by Kolchinsky during the fourth quarter. RA Capital Management currently holds 7.09 million shares reportedly worth a little over $113 million. Wave Life Sciences Ltd (NASDAQ:WVE) focuses on the research and development of treatments for rare genetic diseases, and has a wide array of drug candidates it plans to start trials over the next two years. Wave Life Sciences Ltd (NASDAQ:WVE) went public in November 2015 at $16.00 per share and has been trading sideways since then.

Peter Kolchinsky has also elected to play safe with Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) and has slightly decreased his holding of the stock. RA Capital owns 11.2 million shares, down by 5% over the quarter, valued at $121 million. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is up by more than 5% this morning, having released fourth quarter financial results before the bell. The company said it registered a profit of $17 million or $0.12 per share, beating analysts’ expectations of $0.09 per share. Revenues came in at $31.6 million, also topping Wall Street’s estimates of $31.4 million. These results might provide Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) with further support, after the stock slumped by 37% since the start of the year and settled around the $7 level.

Disclosure: none.